Thomas A. Ciulla, MD, MBA, recalls a period during training at Harvard Medical School in which the application of lasers was standard treatment for exudative age-related macular degeneration (AMD), ...

A recent study published in JAMA Network Open reveals that higher levels of exposure to outdoor artificial light at night can increase the risk of incident exudative age-related macular degeneration.

Exposure to outdoor artificial light at night could be linked to the onset of age-related macular degeneration, a chronic condition that is a leading source of irreversible blindness, South Korean ...

Early in her career, Vaidehi Dedania, MD, encountered a patient with exudative age-related macular degeneration who faced worsening vision and challenges to practicing as a nurse due to the condition.

"It is not necessary to measure the extent, height, or length of the DLS [double layer sign]. It is sufficient to know, however, that when DLS is seen that it’s a key risk factor and that regular ...

Patients with a confirmed diagnosis of OSA were compared to a control group without OSA to assess nonadvanced AMD progression. At 5 years, participants with OSA had a significantly higher risk of both ...

Dr. Michael Scott Mayo Foundation for Medical Education and Research Age-related macular degeneration is the No. 1 cause of vision loss for adults over 50. It may run in families but not always, so a ...

Patients using GLP-1 receptor agonists appear to have a lower risk of age-related macular degeneration and primary open-angle glaucoma. Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) ...

Patients with age-related macular degeneration (AMD) initially may present with distortions in fine visual perception, and disease may be asymptomatic. As the disease develops over time, vision ...

Age-related macular degeneration (AMD) has a worldwide incidence of between 30 and 50 million people and is expected to affect up to 288 million people by the year 2040. Globally, AMD constitutes 6% ...